Sinopharm increases vaccine production to meet demand
Feb 27, 2021
2 minutes
SHIFAAN RYKLIEF
JEKESAI NJIKIZANA
AFP
WITH more than 43 million doses of the Sinopharm Covid-19 vaccine being used globally, the Chinese state-owned biotech company is ramping up production to exceed one billion doses this year.
The Beijing-based company has developed two Covid-19
You’re reading a preview, subscribe to read more.
Start your free 30 days